In trading on Friday, shares of ARS Pharmaceuticals Inc (Symbol: SPRY) crossed below their 200 day moving average of $11.90, changing hands as low as $11.89 per share. ARS Pharmaceuticals Inc ...

San Francisco-based Spry Health has raised $5.5 million to progress its clinical-grade wristband wearable, Loop. The money was raised in a series A funding round led by Grove Ventures and the ...

In a report released today, Ryan Deschner from Raymond James maintained a Buy rating on ARS Pharmaceuticals (SPRY – Research Report), with a price target of $28.00. The company’s shares closed ...